{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2021"],"condition":["metastatic colorectal cancer"],"disease":["Metastatic Colorectal Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/81286"],"location":["China"],"study_start_month":["12"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"A Retrospective-Prospective observational study in China to describe the management in clinical practice of adult patients with metastatic colorectal cancer (CRC) with a BRAF V600E  mutation who have received prior systemic therapy","description":"Interventions: Retrospective group:None;Prospective group:None\nPrimary outcome(s): Describe the treatment path of the target population\nStudy Design: Sequential","dates":{"creation":"2021-12-15"},"accession":"81286","cross_references":{"Chinese Clinical Trial Register":["ChiCTR2200065134"]}}